Home » Newsletters » BioWorld

BioWorld

Aug. 20, 1992

View Archived Issues

LEECO TO RESTRUCTURE

RAPID GROWTH OF AG BIOTECH SEEN

NEOGEN TO DEVELOP TESTS FOR PFIZER

NAVY CONTRACT FOR NORTH AMERICAN BIOLOGICALS

TRANSGENIC FIRM AWAITS IPO

ARGUS PATENT ALLOWED FOR ANTI-FUNGAL

DEVELOPERS EYE HERD OF PRODUCTS

ITALY APPPROVES CENTOXIN

AMGEN TO BUY BACK STOCK

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...